Article
Genome-wide association study identifies RBFOX1 locus influencing brain glucose metabolism
1 Nov 2018
Abstract excerpt
BACKGROUND: Fluorodeoxyglucose f18 positron emission tomography (18F-FDG PET) is regarded as the only functional neuroimaging biomarker for degeneration which can be used to increase the certainty of Alzheimer's disease (AD) pathophysiological process in research settings or as an optional clinical tool where available. Although a decline in FDG metabolism was confirmed in some regions known to be associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
